Atlas Trials

A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients

Clinical trial NCT05659602 · COMPLETED

Trial details

NCT number
NCT05659602
Sponsor
Beijing Ditan Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronavirus Disease 2019(COVID-19)
Start date
2022-07-09
Primary completion
2023-01-03
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.